Actuate Therapeutics
(NASDAQ) ACTU
Actuate Therapeutics Financials at a Glance
Market Cap
$52.76M
Revenue (TTM)
$0.00
Net Income (TTM)
$24.12M
EPS (TTM)
$-1.21
P/E Ratio
-1.88
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Price
$2.16
Volume
591
Open
$2.08
Price
$2.16
Volume
591
Open
$2.08
Previous Close
$2.16
Daily Range
$2.08 - $2.23
52-Week Range
$2.05 - $11.99
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Price
$2.16
Volume
591
Open
$2.08
Previous Close
$2.16
Daily Range
$2.08 - $2.23
52-Week Range
$2.05 - $11.99
ACTU News
ACTU: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Actuate Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
12
CEO
Daniel M. Schmitt, MBA
Website
www.actuatetherapeutics.comHeadquarters
Fort Worth, TX 76107, US
ACTU Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-296%
Return on Capital
-3%
Return on Assets
-2%
Earnings Yield
-53.19%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$52.76M
Shares Outstanding
23.24M
Volume
591
Short Interest
0.00%
Avg. Volume
73.51K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$22.50M
EBITDA
$22.50M
Operating Cash Flow
$19.21M
Capital Expenditure
$0.00
Free Cash Flow
$19.21M
Cash & ST Invst.
$13.16M
Total Debt
$0.00
Actuate Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$52.76M
N/A
Market Cap/Employee
$5.28M
N/A
Employees
10
N/A
Net Income
$5.41M
+9.4%
EBITDA
$5.40M
+9.5%
Quarterly Fundamentals
Net Cash
$13.16M
+52.3%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-1.72%
N/A
Return on Invested Capital
-2.93%
N/A
Free Cash Flow
$3.74M
+21.7%
Operating Cash Flow
$3.74M
+21.7%